Paul Surdez
Investor Relations Contact at CATALENT, INC.
Profile
Paul Surdez is currently the Vice President-Investor Relations at Catalent, Inc. He previously held the same position at Laboratory Corp.
of America Holdings and Labcorp Drug Development, Inc.
Paul Surdez active positions
| Companies | Position | Start |
|---|---|---|
| CATALENT, INC. | Investor Relations Contact | 2020-01-06 |
Former positions of Paul Surdez
| Companies | Position | End |
|---|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Investor Relations Contact | - |
| COVANCE INC. | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
| CATALENT, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Paul Surdez
